Clinical Trial Update: Beta Alethine in Treating Patients With Low-Grade Lymphoma [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update covers the Phase 1/Phase 2 study of Beta Alethine in patients with low-grade non-Hodgkin lymphoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Low-grade Non-hodgkin Lymphoma
• Non-hodgkin Lymphoma

Drugs mentioned

• Beta Alethine (beta alethine)

Snippet

Sponsor: LifeTime Pharmaceuticals | Conditions: Lymphoma | Phase 1, Phase 2 | Status: UNKNOWN